Llwytho...
Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
Pancreatic cancer is the fourth leading cause of death from cancer in both men and women. Pancreatic cancer is typically diagnosed at an advanced stage and has an overall 5-year survival of approximately 9.3%. The National Comprehensive Cancer Network recommends both germline testing (testing cells...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Adv Pract Oncol |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Harborside Press LLC
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8299794/ https://ncbi.nlm.nih.gov/pubmed/34430059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2021.12.5.4 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|